Reactive airway dysfunction syndrome due to sodium azide inhalation

International Archives of Occupational and Environmental Health

Volumn 68, Issue 6, 1996, Pages 469-471

  Weiss, Janet S ^a  

^a Toxicology Consultant   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; SODIUM AZIDE; STEROID;

ADULT; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; HUMAN; INHALATION; INHALATIONAL DRUG ADMINISTRATION; MALE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; RESPIRATORY TRACT DISEASE;

EID: 0029791012     PISSN: 03400131     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00377871     Document Type: Conference Paper

References (22)

1. Buckheit and Fan Sodium azide in automotive airbags. National Highway Traffic Safety Administration, U.S. Department of Transportation, Washington, DC. 1978
2. Templeton JC, King EL (1971) Kinetic and equilibrium studies on Azidochromium(III) ion in concentrated perchloric acid. J Am Chem Soc 93: 7160
3. Smith RP, Wilcox DE (1994) Toxicology of selected nitric oxide-donating xenobiotics with particular reference to azide. Crit Rev Toxicol 24: 355
4. Brooks S, Weiss MA, Bernstein IL (1985) Reactive airways dysfunction syndrome (RADS) Persistent asthma syndrome after high level irritant exposures. Chest 88: 376
5. Smith RP, Louis CA, Kruszyna R, Rruszyna H (1991) Acute neurotoxicity of sodium azide and nitric oxide. Fundam Appl Toxicol 17: 120-127
6. Kruszyna H, Kruszyna R, Smith RP, Wilcox DE (1988) Red blood cells generate nitric oxide from directly acting, nitrogenous vasodilators. Toxicol Appl Pharmacol 94: 458
7. Ignarr LJ (1991) Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol 41: 485
8. Marletta MA (1989) Nitric oxide: biosynthesis and biological significance. TIBS 14: 488
9. Smith RP, Gosselin RE (1966) On the mechanism of sulfide inactivation by methemoglobin. Toxicol Appl Pharmacol 8: 159
10. Smith L, Kruszyna H, Smith RP (1977) The effect of methemoglobin on the inhibition of cytochrome c oxidase by cyanide, sulfide or azide. Biochem Pharmacol 26: 2247
11. Kalyanaraman B, Janzen EG, Mason RP (1985) Spin trapping of the azidyl radical in azide/catalase/H2O2 and various azide/ peroxide/H2O2 peroxidizing systems. J Biol Chem 260: 4003
12. Nicholls P (1964) The reactions of azide with catalase and their significance. Biochem J 90: 331
13. Sono M, Dawson JH (1982) Formation of low spin complexes of ferric cytochrome p-450-CAM with anionic ligands. J Biol Chem 257: 5496
14. Curzon G (1966) The inhibition of ceruloplasmin by azide. Biochem J 100: 295
15. Blackburn NJ, Collison D, Sutton J Mabbs FE (1984) Kinetic and EPR studies of cyanide and azide binding to the copper sites of dopamine B-mono-oxygenase. Biochem J 220: 447
16. Amaral D, Bernstein L, Morse D, Horecker BL (1963) Galactose oxidase of Polyporus circinatus: a copper enzyme. J Biol Chem 238: 2281
17. Healey DF, Strothkamp KG (1981) Inhibition of the catecholase and cresolase activity of mushroom tyrosinase by azide. Arch Biochem Biophys 221: 86
18. Lindstrom A, Olsson B, Pettersson G (1974) Effect of azide on some spectral and kinetic properties of pig-plasma benzyl-amine oxidase. Eur J Biochem 48: 237
19. Misra HP, Fridovich I (1978) Inhibition of Superoxide dismutases by azide. Arch Biochem Biophys 189: 317
20. Rubinstein E, Urso I, Carroll R (1992) Low concentrations of sodium azide specifically inhibit a thromboxane A2 pathway in human platelets. Thrombosis Res 66: 101
21. National Toxicology Program, Toxicology and Carcinogenesis Studies of Sodium Azide (CAS No. 26628-22-8) in F344/N Rats (Gavage studies). National Toxicology Program Tech. Report No. 389, PB92-13561590 USDHHS, USPHS, NIH, Publ. No. 91-2844, Sept. 1991
22. Arenaz P, Hallberg L, Mancillas F, Gutierrez G, Garcia S (1989) Sodium azide mutagenesis in mammals: inability of mammalian cells to convert azide to a mutagenic intermediate. Mutation Res 227: 63